Doxycycline Hyclate Tablet, Delayed Release
Product Images NDC 43547-462

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Doxycycline Hyclate (NDC 43547-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spl Image1 Structure)

Chemical structure of doxycycline hyclate shown as a detailed molecular diagram with hydroxyl, carbonyl, methyl, amide, and amine groups indicated. The structure also includes the hydrochloride, ethanol, and water components as part of the molecular formula.*

FDA Label Image

Spl Image10 200mg Label

Label for Doxycycline Hyclate Delayed-Release Tablets, USP, 200 mg strength, containing 60 tablets. The label includes usage instructions, storage conditions (20-25°C, excursions allowed to 15-30°C), and a caution not to chew or crush tablets. Manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd., China, and distributed by Solco Healthcare US LLC, Somerset, NJ.*

FDA Label Image

150 mg Treatment (Spl Image2 150mg Treatment)

Illustrations of a doxycycline hyclate delayed release tablet showing top and side views with imprints P 0 1, and a side view of the tablet being held between thumbs and index fingers, demonstrating its size and shape.*

FDA Label Image

100 mg Treatment (Spl Image3 100mg Treatment)

Illustrations of the DOXYCYCLINE HYCLATE delayed release oral tablet showing a top view and side view of the tablet, as well as a depiction of the tablet being held between thumbs and index fingers to indicate size or handling. The top view includes partial marking details visible on the tablet.*

FDA Label Image

50 mg Treatment (Spl Image4 50mg Treatment)

Illustrations showing the design of a DOXYCYCLINE HYCLATE delayed-release tablet. The first view shows the tablet's top with imprint 'P', the second is a side view of the tablet, and the third depicts a one-third size side view held between a thumb and index finger for scale.*

FDA Label Image

Image Description (Spl Image5 150mg Treatment)

Illustrations showing the DOXYCYCLINE HYCLATE delayed-release tablet from different perspectives: a top view displaying the tablet imprint "P 0 1," a side view highlighting the tablet's thickness and score lines, and a side view of the tablet being held between thumbs and index fingers, demonstrating its size and shape.*

FDA Label Image

Image Description (Spl Image6 100mg Treatment)

Illustrations showing the doxycycline hyclate delayed release tablet from multiple angles: a top view marked with imprint 'PO', a side view displaying the tablet's profile, and a demonstration of tablet size held between thumbs and index fingers.*

FDA Label Image

Image Description (Spl Image7 50mg Treatment)

Illustration showing the tablet shape and size for DOXYCYCLINE HYCLATE delayed-release oral tablets. Includes a top view with tablet imprint 'P', a side view highlighting the tablet's bisected shape, and a scale comparison with thumb and index finger holding approximately one third of the tablet's thickness.*

FDA Label Image

Spl Image8 50mg Label

Packaging label for Doxycycline Hyclate Delayed-Release Tablets, USP, 50 mg strength, in a bottle containing 120 tablets. The label indicates that these are prescription only oral tablets with coated pellets. The product is distributed by Solco Healthcare US LLC, Somerset, NJ, USA, and manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd., China. Storage and handling instructions are also included.*

FDA Label Image

Spl Image9 150mg Label

Label for Doxycycline Hyclate Delayed-Release Tablets USP, 150 mg, oral dosage form by Solco Healthcare US LLC. The package contains 60 tablets. The label includes storage instructions, manufacturer details (Zhejiang Huahai Pharmaceutical Co., Ltd., China), and a barcode. It states not to chew or crush tablets and indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.